Literature DB >> 17938964

A new syndrome with noncompaction cardiomyopathy, bradycardia, pulmonary stenosis, atrial septal defect and heterotaxy with suggestive linkage to chromosome 6p.

Marja W Wessels1, Bianca M De Graaf, Titia E Cohen-Overbeek, Silja E Spitaels, Lotte E de Groot-de Laat, Folkert J Ten Cate, Ingrid F M Frohn-Mulder, Ronald de Krijger, Margot M Bartelings, Nienke Essed, Jury W Wladimiroff, Martinus F Niermeijer, Peter Heutink, Ben A Oostra, Dennis Dooijes, Aida M Bertoli-Avella, Patrick J Willems.   

Abstract

We report a three-generation family with nine patients affected by a combination of cardiac abnormalities and left isomerism which, to our knowledge, has not been described before. The cardiac anomalies include non-compaction of the ventricular myocardium, bradycardia, pulmonary valve stenosis, and secundum atrial septal defect. The laterality sequence anomalies include left bronchial isomerism, azygous continuation of the inferior vena cava, polysplenia and intestinal malrotation, all compatible with left isomerism. This new syndrome is inherited in an autosomal dominant pattern. A genome-wide linkage analysis suggested linkage to chromosome 6p24.3-21.2 with a maximum LOD score of 2.7 at marker D6S276. The linkage interval is located between markers D6S470 (telomeric side) and D6S1610 (centromeric side), and overlaps with the linkage interval in another family with heterotaxy reported previously. Taken together, the genomic region could be reduced to 9.4 cM (12 Mb) containing several functional candidate genes for this complex heterotaxy phenotype.

Entities:  

Mesh:

Year:  2007        PMID: 17938964     DOI: 10.1007/s00439-007-0436-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  47 in total

1.  Familial isolated noncompaction of the left ventricular myocardium.

Authors:  K Kurosaki; U Ikeda; Y Hojo; H Fujikawa; T Katsuki; K Shimada
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

2.  Isomerism of the left atrial appendage associated with ventricular noncompaction.

Authors:  Mark K Friedberg; Philip C Ursell; Norman H Silverman
Journal:  Am J Cardiol       Date:  2005-10-01       Impact factor: 2.778

3.  Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors.

Authors:  Susan E Crawford; Chao Qi; Parimal Misra; Veronica Stellmach; M Sambasiva Rao; James D Engel; Yijun Zhu; Janardan K Reddy
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

4.  Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome.

Authors:  S B Bleyl; B R Mumford; V Thompson; J C Carey; T J Pysher; T K Chin; K Ward
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

5.  Situs inversus totalis associated with subaortic and subpulmonic stenosis.

Authors:  D E Wells; B Befeler
Journal:  Chest       Date:  1975-01       Impact factor: 9.410

6.  Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block.

Authors:  Mohammad Pashmforoush; Jonathan T Lu; Hanying Chen; Tara St Amand; Richard Kondo; Sylvain Pradervand; Sylvia M Evans; Bob Clark; James R Feramisco; Wayne Giles; Siew Yen Ho; D Woodrow Benson; Michael Silberbach; Weinian Shou; Kenneth R Chien
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

7.  Chylothorax in a polysplenia infant with cor triatriatum, pulmonary stenosis and sick sinus syndrome.

Authors:  A Noguchi; T Ito; M Tamura; K Harada; G Takada
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

8.  Isolated levocardia associated with absence of inferior vena cava, lobulated spleen and sick sinus syndrome. A case report.

Authors:  H Kakura; K Miyahara; H Sohara; S Amitani; M Koga; Y Moriyama; A Taira
Journal:  Jpn Heart J       Date:  1998-03

9.  Node and midline defects are associated with left-right development in Delta1 mutant embryos.

Authors:  Gerhard K H Przemeck; Ulrich Heinzmann; Johannes Beckers; Martin Hrabé de Angelis
Journal:  Development       Date:  2003-01       Impact factor: 6.868

10.  Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations.

Authors:  Manuel Hermida-Prieto; Lorenzo Monserrat; Alfonso Castro-Beiras; Rafael Laredo; Rafaela Soler; Jesus Peteiro; Esther Rodríguez; Beatriz Bouzas; Nemesio Alvarez; Javier Muñiz; Marisa Crespo-Leiro
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

View more
  13 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  NPHP4 variants are associated with pleiotropic heart malformations.

Authors:  Vanessa M French; Ingrid M B H van de Laar; Marja W Wessels; Christan Rohe; Jolien W Roos-Hesselink; Guangliang Wang; Ingrid M E Frohn-Mulder; Lies-Anne Severijnen; Bianca M de Graaf; Rachel Schot; Guido Breedveld; Edwin Mientjes; Marianne van Tienhoven; Elodie Jadot; Zhengxin Jiang; Annemieke Verkerk; Sigrid Swagemakers; Hanka Venselaar; Zohreh Rahimi; Hossein Najmabadi; Hanne Meijers-Heijboer; Esther de Graaff; Wim A Helbing; Rob Willemsen; Koen Devriendt; John W Belmont; Ben A Oostra; Jeffrey D Amack; Aida M Bertoli-Avella
Journal:  Circ Res       Date:  2012-05-01       Impact factor: 17.367

3.  Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects.

Authors:  A J Agopian; Elizabeth Goldmuntz; Hakon Hakonarson; Anshuman Sewda; Deanne Taylor; Laura E Mitchell
Journal:  Circ Cardiovasc Genet       Date:  2017-06

4.  A novel autosomal dominant condition consisting of congenital heart defects and low atrial rhythm maps to chromosome 9q.

Authors:  Judith B A van de Meerakker; Klaartje van Engelen; Inge B Mathijssen; Ronald H Lekanne dit Deprez; Jan Lam; Arthur A M Wilde; Marieke J H Baars; Marcel M A M Mannens; Barbara J M Mulder; Antoon F M Moorman; Alex V Postma
Journal:  Eur J Hum Genet       Date:  2011-03-09       Impact factor: 4.246

5.  A genome-wide association study of obstructive heart defects among participants in the National Birth Defects Prevention Study.

Authors:  Sara R Rashkin; Mario Cleves; Gary M Shaw; Wendy N Nembhard; Eirini Nestoridi; Mary M Jenkins; Paul A Romitti; Xiang-Yang Lou; Marilyn L Browne; Laura E Mitchell; Andrew F Olshan; Kevin Lomangino; Sudeepa Bhattacharyya; John S Witte; Charlotte A Hobbs
Journal:  Am J Med Genet A       Date:  2022-04-22       Impact factor: 2.578

Review 6.  Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction.

Authors:  Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2009-01-29       Impact factor: 1.655

Review 7.  Cardiac Embryology and Molecular Mechanisms of Congenital Heart Disease: A Primer for Anesthesiologists.

Authors:  Benjamin Kloesel; James A DiNardo; Simon C Body
Journal:  Anesth Analg       Date:  2016-09       Impact factor: 5.108

Review 8.  Heart failure in congenital heart disease: a confluence of acquired and congenital.

Authors:  Akl C Fahed; Amy E Roberts; Seema Mital; Neal K Lakdawala
Journal:  Heart Fail Clin       Date:  2014-01       Impact factor: 3.179

9.  Identification of RNA binding motif proteins essential for cardiovascular development.

Authors:  Samantha Maragh; Ronald A Miller; Seneca L Bessling; David M McGaughey; Marja W Wessels; Bianca de Graaf; Eric A Stone; Aida M Bertoli-Avella; John D Gearhart; Shannon Fisher; Andrew S McCallion
Journal:  BMC Dev Biol       Date:  2011-10-19       Impact factor: 1.978

10.  Left ventricular hypertrabeculation/noncompaction with epilepsy, other heart defects, minor facial anomalies and new copy number variants.

Authors:  Bert Nagel; Ursula Gruber-Sedlmayr; Sabine Uhrig; Claudia Stöllberger; Eva Klopocki; Josef Finsterer
Journal:  BMC Med Genet       Date:  2012-07-25       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.